What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses
Authors
Vale, CRydzewska, L
Tierney, J
Albiges, L
Clarke, Noel W
Fisher, D
Fizazi, K
James, N
Mason, M
Parmar, M
Sweeney, C
Sydes, M
Tombal, B
Burdett, S
Affiliation
MRC Clinical Trials Unit at UCL, Meta-analysis Group, London,Issue Date
2015